Leading Edge of Cancer Research Symposium
 

Files

Download

Download Poster (3.8 MB)

DOI

https://doi.org/10.52519/00062

Streaming Media

Publication Date

2022

Department

Endocrine Neoplasia and Hormonal Disorders

Research Category

The Patient is the Focus

Therapeutic Potential of Ralimetinib, a p38/MAPK14 Inhibitor, in Anaplastic Thyroid Cancer

View Online

Share

COinS